NasdaqGS - Delayed Quote USD
ORIC Pharmaceuticals, Inc. (ORIC)
9.32
+0.16
+(1.75%)
At close: June 6 at 4:00:00 PM EDT
9.17
-0.15
(-1.61%)
After hours: June 6 at 7:31:58 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 163,250 | 4 |
| Sales | 42,361 | 3 |
| Net Shares Purchased (Sold) | 120,889 | 7 |
| Total Insider Shares Held | 6.8M | -- |
| % Net Shares Purchased (Sold) | 1.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KUNKEL LORI ANNE Director | Conversion of Exercise of derivative security at price 3.75 - 6.33 per share. | Direct | 233,512 | Mar 3, 2025 |
| MULTANI PRATIK S Officer | Sale at price 8.28 per share. | Direct | 73,293 | Dec 16, 2024 |
| CHACKO JACOB M Chief Executive Officer | Sale at price 8.28 per share. | Direct | 204,214 | Dec 16, 2024 |
| PISCITELLI DOMINIC G. Chief Financial Officer | Sale at price 8.28 per share. | Direct | 73,298 | Dec 16, 2024 |
| MULTANI PRATIK S Officer | -- | Direct | -- | Dec 13, 2024 |
| CHACKO JACOB M Chief Executive Officer | -- | Direct | -- | Dec 13, 2024 |
| PISCITELLI DOMINIC G. Chief Financial Officer | -- | Direct | -- | Dec 13, 2024 |
| KUNKEL LORI ANNE Director | Conversion of Exercise of derivative security at price 3.75 per share. | Direct | 76,875 | Jun 3, 2024 |
| CHACKO JACOB M Chief Executive Officer | Sale at price 16.21 per share. | Direct | 648,380 | Mar 6, 2024 |
| CHACKO JACOB M Chief Executive Officer | Sale at price 12.12 - 12.30 per share. | Direct | 489,346 | Feb 7, 2024 |
| MULTANI PRATIK S Officer | -- | Direct | -- | Dec 15, 2023 |
| CHACKO JACOB M Chief Executive Officer | -- | Direct | -- | Dec 15, 2023 |
| PISCITELLI DOMINIC G. Chief Financial Officer | -- | Direct | -- | Dec 15, 2023 |
| MULTANI PRATIK S Officer | Sale at price 8.59 per share. | Direct | 45,351 | Dec 15, 2023 |
| CHACKO JACOB M Chief Executive Officer | Sale at price 8.58 per share. | Direct | 124,813 | Dec 15, 2023 |
| PISCITELLI DOMINIC G. Chief Financial Officer | Sale at price 8.58 per share. | Direct | 45,338 | Dec 15, 2023 |
| CHACKO JACOB M Chief Executive Officer | Sale at price 8.01 per share. | Direct | 125,499 | Jul 11, 2023 |
| CHACKO JACOB M Chief Executive Officer | Sale at price 8.01 per share. | Direct | 34,711 | Jul 5, 2023 |
| CHACKO JACOB M Chief Executive Officer | Sale at price 8.03 per share. | Direct | 160,562 | Jun 26, 2023 |
Related Tickers
PLRX Pliant Therapeutics, Inc.
1.6300
+1.24%
PASG Passage Bio, Inc.
0.4228
-6.04%
BDTX Black Diamond Therapeutics, Inc.
2.5800
+3.61%
STOK Stoke Therapeutics, Inc.
11.14
+2.39%
TNGX Tango Therapeutics, Inc.
4.2600
+21.37%
NRIX Nurix Therapeutics, Inc.
12.78
+2.24%
ITOS iTeos Therapeutics, Inc.
10.17
-0.10%
ANAB AnaptysBio, Inc.
23.70
+12.11%
RVMD Revolution Medicines, Inc.
41.09
+2.21%
REPL Replimune Group, Inc.
10.38
+6.46%